Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-045615
Filing Date
2010-05-06
Accepted
2010-05-06 17:00:56
Documents
14
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v55296ae10vk.htm 10-K 1655802
2 EX-2.1.B v55296aexv2w1wb.htm EX-2.1.B 9919
3 EX-10.25.B v55296aexv10w25wb.htm EX-10.25.B 8520
4 EX-10.41 v55296aexv10w41.htm EX-10.41 64672
5 EX-10.42 v55296aexv10w42.htm EX-10.42 15158
6 EX-18.1 v55296aexv18w1.htm EX-18.1 2220
7 EX-21.1 v55296aexv21w1.htm EX-21.1 2891
8 EX-23.1 v55296aexv23w1.htm EX-23.1 1698
9 EX-23.2 v55296aexv23w2.htm EX-23.2 1910
10 EX-31.1 v55296aexv31w1.htm EX-31.1 5749
11 EX-31.2 v55296aexv31w2.htm EX-31.2 5977
12 EX-32.1 v55296aexv32w1.htm EX-32.1 3394
13 EX-32.2 v55296aexv32w2.htm EX-32.2 3246
14 GRAPHIC v55296av5529603.gif GRAPHIC 9847
  Complete submission text file 0000950123-10-045615.txt   1796412
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Filer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
Type: 10-K | Act: 34 | File No.: 001-33882 | Film No.: 10808975
SIC: 8731 Services-Commercial Physical & Biological Research